Trial intelligence / Profile preview

Pyrotinib combined with EC-TH for de novo metastatic HER2-positive breast cancer

ChiCTR2200058269Phase 4Not yet recruiting

Sponsor

Southwest Hospital of Army Medical University

Start

Apr 2022

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1